Breaking The University-Industry Technology Transfer Logjam

January 22, 1999

Patents fuel the global economic engine. Please join a panel of distinguished academic and industry leaders for a groundbreaking discussion on the challenges facing patent buyers and sellers. Organized by Nir Kossovsky, founder of The Patent and License ExchangeSM auction market, and hosted by Rob Golum, associate editor of Investors Business Daily, the panel discussion will be held in connection with the American Association for The Advancement of Science's annual conference, "Challenges For A New Century."

Discussion will address the road blocks and challenges that confront university and industry technology transfer as well as solutions for capturing the hundreds of millions of dollars lost annually due to the inefficient global patent and license transfer process.

Speakers will include:
Nir Kossovsky will be available for one-on-one press interviews following the panel discussion to address trends in global patent and technology transfer.

WHEN: Friday, January 22, 1999 9:00 a.m. to 12 noon

WHERE: Anaheim Hilton & Towers, 4th Floor

ROOM: El Capitan A

American Association for the Advancement of Science (AAAS) Annual Meeting "Challenges For A New Century Conference"


The Patent and License ExchangeSM patent auction market ("plXSM") is the first business-to-business global Internet-based auction facility for the safe and efficient commercial transfer of quality, patents and licenses. plX brings together global patent buyers and sellers, provides standardized information on patent inventory, offers patent validity, infringement and enforcement insurance, posts transparent and reasonable proposed terms of sale, expedites the market clearing process, and provides cost-effective aftermarket licensing administration. Trading will begin this summer. For more information visit
Jamie Ludowitz

Fleishman-Hillard, Inc.

Related Patents Articles from Brightsurf:

Cities beat suburbs at inspiring cutting-edge innovations
The disruptive inventions that make people go ''Wow!'' tend to come from research in the heart of cities and not in the suburbs, a new study suggests.

It's not about money -- why academic scientists engage in commercial activities
For scientists, engaging in commercial activities such as patenting and starting new ventures can be much more lucrative than relying on pure academic work.

Government-funded research increasingly fuels innovation
A quantitative analysis going back over a period of more than 90 years shows that almost a third of patents in the U.S. rely on federal research funding.

Green tech startups see boost in patents and investment when partnering with government
Collaboration between government and startups could help meet the climate challenge while growing small businesses.

Companies with more financial analysts produce more and better-quality patents
Long-term growth in profits depends significantly on firms' investment in innovation activities.

This computer program makes pharma patents airtight
Routes to making life-saving medications and other pharmaceutical compounds are among the most carefully protected trade secrets in global industry.

US companies are investing less in science
A new article reveals that large corporations are investing less in science.

Probiotics: Novel biosynthetic tool to develop metallic nanoparticles
Probiotics, being live microbes, exert numerous beneficial health effects on the host cells.

Study: Being near colleagues helps cross-disciplinary research on papers and patents
Want to boost collaboration among researchers? Even in an age of easy virtual communication, physical proximity increases collaborative activity among academic scholars, according to a new study examining a decade's worth of MIT-based papers and patents.

Virus-derived expression vectors as gene therapy vehicles
Even as new viruses are being identified, the emerging field of virus discovery, identification of their nucleotide sequences, gene expression patterns and complexities of virus-host interactions at the molecular level are being used in recent years towards applications in the human medicine as well as veterinary, agricultural and other biotechnological purposes.

Read More: Patents News and Patents Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to